SCHULMAN AMY W 4

What Happened Amy W. Schulman, a director of Elevance Health, sold 26 shares of ELV on March 12, 2026, at $287.50 per share, generating proceeds of $7,475. The sale was reported as an open-market or private sale (code S). The filing notes the sale was executed by a broker under discretionary authority and was not directed or consented to by Schulman.

Key Details

• Transaction date: 2026-03-12; Price: $287.50 per share; Shares sold: 26; Proceeds: $7,475.
• Shares owned after the transaction: not specified in this Form 4.
• Reason/footnote: Shares had been acquired on Schulman’s behalf under broker discretionary authority prior to her joining the board; those shares were omitted from prior beneficial ownership totals due to administrative error.
• Sale executed by broker without reporting person's direction.
• Filing timeliness: this Form 4 was filed late (transactionTimeliness = L); the filer says it is being submitted promptly after discovery of the sale.

Context This was a small-dollar sale executed by a broker under discretionary authority and reported after the fact. Such routine sales—especially when performed by a broker without the insider’s direction—generally do not by themselves indicate management sentiment about the company. The late filing is an administrative compliance issue but does not change the basic facts of the transaction.